3D Printed Medical Devices Market to Cross US$ 1,737.5 Million at a CAGR of 18.4% by 2027

-



In the healthcare industry, 3D printing technology is utilised to produce medical items like orthopaedic and cranial implants, surgical instruments, dental restorations like crowns, and external prostheses. Several processes make up the manufacturing process, depending on the kind of medical equipment needed. Medical equipment made with 3D printing can be modified to meet the needs of the patient.

The 3D Printed Medical Devices Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this 3D Printed Medical Devices Market report is to supply an in-depth view and strategic analysis of the parent industry.

Market drivers for 3D-printed medical devices worldwide

The high frequency of bone-dental diseases, osteoarthritis, diabetes-related gangrene, periodontitis, and osteoarthritis is anticipated to spur expansion in the global market for 3D printed medical products. For instance, periodontal disease prevalence in southern India was found to be 42.3% in April 2018 by Sri Ramachandra University researchers in India.

Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K., Bio3D Technologies, PrinterPrezz, Carima, Nexxt Spine, and Aurora Labs are some of the competitors.

Key features of the study:

    1.  In-depth analysis of the global market for 3D printed medical devices is provided in this study, along with market size (US$ Million) and compound annual growth rate (CAGR%) for the projected period (2019–2027), using 2018 as the base year.

    2.  It explains the market's appealing investment proposal matrix and clarifies the possible revenue opportunity across several categories.

    3.  Important information about the market's drivers, constraints, opportunities, new product releases or approvals, geographical outlook, and competitive strategies used by major competitors are also provided in this analysis.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-
Read more

Infusion Pumps Market to Surpass US$ 5,709.1 Million with a CAGR of 6.1% by 2027

-
Image
A medical device called an infusion pump is used to administer different fluids to the body under controlled conditions. In hospitals, nursing homes, long-term care facilities, and residential settings, the pump is used to provide intravenous medications. Infusion pumps are used in the treatment and management of diabetes, gastroenterology, haematology, neonatology, analgesia, and chemotherapy. The global infusion pumps market is estimated to account for US$ 5,709.1 Mn in terms of value by 2027. Market drivers for infusion pumps worldwide: When treating diabetes, insulin is given by infusion pumps. Therefore, during the course of the forecast period, rising diabetes prevalence is anticipated to fuel market expansion for infusion pumps worldwide. The American Diabetes Association estimates that there were more than 500 million prevalent instances of type 2 diabetes worldwide in 2018. Important aspects of the study: ▪️ In-depth research of the global infusion pump market is provided in
Read more

Herceptin Biosimilars Market Impact of Existing and Emerging Flexible Trends, Promising Growth Opportunities | Forecasts 2022-2028- Coherent Market Insights

-
Image
The  Herceptin Biosimilar Market  is carefully analyzed in the report with an emphasis on market dynamics, including key issues and challenges, drivers, trends, and opportunities. The report includes an in-depth analysis of significant market players to understand the utilization of the main strategies that have been adopted in the Herceptin Biosimilar market. It also sheds light on the industrial value chain and its expected changes over the forecast period. Herceptin is a monoclonal antibody used to treat patients suffering from metastatic (spread) breast cancer and gastric cancers. Hereceptin is used as part of chemotherapy regimen for adjuvant treatment of lymph-node positive, HER2/neu protein positive breast cancer. Herceptin is also known as trastuzumab and mainly administered intravenously in cancer patients, the dose of herceptin given to patients is evaluated on the basis of patients' disease history and other physiological factors such as height, weight, type of cancer or
Read more